Bessemer Group
BLUE

Bessemer Group’s bluebird bio BLUE Stock Holding History

Bessemer Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,764
Closed -$17.2M – 1507
2020
Q4 		$17.2M Hold
30,764
– – 0.05% 195
2020
Q3 		$21.5M Buy
30,764
+5,611
+22% +$4.38M 0.06% 181
2020
Q2 		$19.9M Hold
25,153
– – 0.06% 178
2020
Q1 		$15M Hold
25,153
– – 0.06% 194
2019
Q4 		$28.6M Buy
25,153
+3,443
+16% +$3.74M 0.09% 185
2019
Q3 		$25.8M Buy
21,710
+10,648
+96% +$16.3M 0.09% 176
2019
Q2 		$18.2M Buy
11,062
+11,060
+553,000% +$19.1M 0.06% 202
2019
Q1 		$5K Buy
+2
New +$3.52K ﹤0.01% 1589

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bessemer Group's BLUE Position: Q1 2021 in Review

Bessemer Group sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 30,764 shares — an estimated $17.2M sold.

Bessemer Group first reported a position in BLUE in Q1 2019 and held it in 8 quarters. The position peaked at $28.6M in Q4 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Bessemer Group reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Bessemer Group sold 30,764 bluebird bio shares in Q1 2021, an estimated $17.2M.
  • Bessemer Group first reported a position in bluebird bio in Q1 2019 and held it in 8 quarters.
  • Bessemer Group's bluebird bio position peaked at $28.6M in Q4 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Bessemer Group's 13F filing for Q1 2021, filed 13 May 2021.